Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin and Clindamycin in Inflammatory Facial Acne
NCT03883269Phase 4Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of erythromycin and clindamycin in acne vulgaris, sponsored by Centre for Human Drug Research. Primary endpoint: Change in lesion count at Day 42. Started Mar 2018; status: recruiting.
02
Drugs
erythromycinclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03883269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883269.